4.7 Article

Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biotechnology & Applied Microbiology

A High-throughput Pharmacoviral Approach Identifies Novel Oncolytic Virus Sensitizers

Jean-Simon Diallo et al.

MOLECULAR THERAPY (2010)

Article Biochemistry & Molecular Biology

Targeted depletion of BMI1 sensitizes tumor cells to P53-mediated apoptosis in response to radiation therapy

N. M. Alajez et al.

CELL DEATH AND DIFFERENTIATION (2009)

Article Medicine, General & Internal

Head and neck cancer: Changing epidemiology, diagnosis, and treatment

Shanthi Marur et al.

MAYO CLINIC PROCEEDINGS (2008)

Article Oncology

Imaging and modulating antisense microdistribution in solid human xenograft tumor models

Joseph D. Mocanu et al.

CLINICAL CANCER RESEARCH (2007)

Article Biotechnology & Applied Microbiology

Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow

Caroline J. Breitbach et al.

MOLECULAR THERAPY (2007)

Article Biotechnology & Applied Microbiology

Combination of the oncolytic adenovirus ICOVIR-5 with chemotherapy provides enhanced anti-glioma effect in vivo

M. M. Alonso et al.

CANCER GENE THERAPY (2007)

Article Oncology

ZD6126: A novel small molecule vascular targeting agent

DC Blakey et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)